ClariVein^®, mechanochemical endovenous ablation: patient selection and perspective

Amjad Belramman1 Academic Section of Vascular Surgery, Department of Surgery and Cancer, Imperial College London, London, UK

Roshan Bootun1 Academic Section of Vascular Surgery, Department of Surgery and Cancer, Imperial College London, London, UK;2 East of England Deanery Vascular Surgery Training Programme, Cambridge, UK

Sarah Onida1 Academic Section of Vascular Surgery, Department of Surgery and Cancer, Imperial College London, London, UK;3 Imperial Vascular Unit, Imperial College Healthcare NHS Trust, London, UK

Alun H Davies1 Academic Section of Vascular Surgery, Department of Surgery and Cancer, Imperial College London, London, UK;3 Imperial Vascular Unit, Imperial College Healthcare NHS Trust, London, UK

Tristan RA Lane1 Academic Section of Vascular Surgery, Department of Surgery and Cancer, Imperial College London, London, UK;3 Imperial Vascular Unit, Imperial College Healthcare NHS Trust, London, UKCorrespondence[email protected]

ClariVein^®, mechanochemical endovenous ablation: patient selection and perspective

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

ClariVein®, mechanochemical endovenous ablation: patient selection and perspective

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

ClariVein^®, mechanochemical endovenous ablation: patient selection and perspective